Charterhouse Acquires Labomar S.p.A.

September 7, 2023

Charterhouse Capital Partners has invested in Labomar S.p.A., partnering with founder and CEO Walter Bertin and existing minority shareholder Cleon Capital; Labomar's shares were delisted as part of the transaction. Charterhouse will support Labomar's next phase of growth via a buy-and-build strategy to consolidate fragmented markets and expand the company's CDMO capabilities across food supplements, medical devices and functional cosmetics.

Buyers
Charterhouse Capital Partners LLP, LBM Next (tender offer vehicle)
Targets
Labomar S.p.A.
Industry
Pharmaceuticals
Location
Italy
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.